02/04/2019 12:00:00

Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference

Summit Therapeutics plc 

(‘Summit’ or the ‘Company’)

Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference

Oxford, UK, and Cambridge, MA, US, 2 April 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, announces that Mr Glyn Edwards, Chief Executive Officer, will present at the H. C. Wainwright & Co. Global Life Sciences Conference on 8 April 2019 at 4:10pm BST in London.

A live webcast of the presentation will be available in the Investors section of the Company's website, www.summitplc.com. A replay of the webcast will be available from the same location soon after the live presentation.

About Summit Therapeutics

Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients, and create value for payors and healthcare providers. We are currently developing new mechanism antibiotics for C. difficile infection and gonorrhoea and are using our proprietary Discuva Platform to expand our pipeline. For more information, visit www.summitplc.com and follow us on Twitter @summitplc.

Contacts

Summit

 

 

Glyn Edwards / Richard Pye (UK office)

Tel:

44 (0)1235 443 951
Michelle Avery (US office)

 

+1 617 225 4455

 

 

 

Cairn Financial Advisers LLP (Nominated Adviser)

Tel:

+44 (0)20 7213 0880
Liam Murray / Tony Rawlinson

 

 

 

 

 

N+1 Singer (Joint Broker)

Tel:

+44 (0)20 7496 3000
Aubrey Powell / Jen Boorer, Corporate Finance

Tom Salvesen, Corporate Broking

 

 

 

 

 

Bryan Garnier & Co Limited (Joint Broker)

Tel:

+44 (0)20 7332 2500
Phil Walker / Dominic Wilson

 

 

 

MSL Group (US)

Tel:

+1 781 684 6557
Jon Siegal

 

summit@mslgroup.com

 

 

 

Consilium Strategic Communications (UK)

Tel:

+44 (0)20 3709 5700
Mary-Jane Elliott / Sue Stuart / Jessica Hodgson /

 

summit@consilium-comms.com

Lindsey Neville

 

 

-END-

Summit Master_rgb_png.png

Related content
05 Sep - 
Summit Presented In Vivo Proof of Concept Data for Targ..
04 Sep - 
Summit Therapeutics to Participate in Upcoming Investor..
01 Aug - 
Summit Therapeutics to Present at the Canaccord Genuity..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
UPDATE - Yoko Ono and John Lennon Educational Tour Bus “Imagine A City With No Gun Violence!”
2
Translate Bio Announces Pricing of Public Offering of Common Stock
3
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SAExploration Holdings, Inc. - SAEX
4
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Pluralsight, Inc. - PS
5
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR

Related stock quotes

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 September 2019 06:54:24
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190829.2 - EUROWEB6 - 2019-09-18 07:54:24 - 2019-09-18 06:54:24 - 1000 - Website: OKAY